Since the mid-1970s, health care professionals have expanded on the age-old definition of cancer care to include aspects of cancer control: prevention, detection, diagnosis, treatment, and survivorship. Using the term cancer control continuum to describe this model of healthcare delivery is not only more accurate and pragmatic than using the term continuum of cancer care , but also it expands the traditional focus of cancer care beyond diagnosis and treatment.
Clinical Dimensions of Cancer Prevention
Corporate practices have a dominant influence on
health-related behaviors by influencing the social, physical, and policy
factors that shape individual decisions. As with other health outcomes, many
cancers disproportionately affect people of color and people of low
socioeconomic status (SES). Because
the number of cancer cases in the United States is growing, primary prevention
of cancer is a high priority. However, many people still smoke
cigarettes and eat poorly. Scientists are investigating the causes of cancer,
and they have identified some ways to prevent cancer. We need a more
transdisciplinary and multifaceted approach to cancer prevention, which would
be best suited to different age groups and population segments.
The medical
advancement and measures which are responsible for cancer prevention are
1)
Cancer immunotherapy combines cancer treatment
and prevention. Immunotherapies activate, recruit and/or enhance an individuals
own immune system to specifically target and destroy cancer cells. Clinical
evidence has shown that cancer immunotherapy can block the progression from
normal cells to cancer cells, eliminate existing cancers and help the body
fight off future cancers using the patients own immune system. Recent
breakthroughs are offering new hope for the treatment of many types of cancers.
2)
The incidence of cancer is rising at an alarming rate.
The good news is that lifestyle and medical interventions have been proven to
be effective in preventing certain cancers.
3)
In situ cancers are very dangerous. They can be fatal
if not discovered early enough and have a high potential of becoming invasive.
New advances in medical treatment to work on both the early detection and pre-cancerous
phase of in situ cancer in a way when it is less harmful. These
treatments are especially important since these types of cancer are the least
detectable by mammograms and other common forms of cancer screening.
4)
Immunotherapy, the use of the immune system to fight
cancer and other diseases, is going through a golden age. Since 1980, we’ve
seen the development of vaccines against hepatitis B and human papilloma virus
(HPV)-related cancers, as well as efforts to create immune response modulation
strategies for numerous cancers, including those that are difficult to treat.
And new vaccines are on the horizon. The hope is that adding vaccines to our
arsenal of treatments for cancer,
surgery, radiation therapy and chemotherapy, will extend how long
patients live with their disease and improve their quality of life.
5)
The future of cancer prevention is on the
horizon. Multidisciplinary research efforts include collaborations between
diagnostic imaging technology experts and information technologists to improve
current diagnosis technique and they are developing new strategies to diagnose
cancer early. This collaboration has led to a new period of advances in
communicative medicine.
The underlying premise is one in which precision medicine
leverages technology and expertise in communication to provide clinicians and
their patients with better outcomes than those realized using the traditional
paradigm.
Comments
Post a Comment